- Telehealth Visits
- Insurance plan information
Pamela Marcott, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
Pamela Marcott, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Neurological Surgery
Degree
- MD, Case Western Reserve University
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223445%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223445%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 11 reviews
- September 23, 20255 out of 5 Stars
I loved her, she was very open, willing to engage and answered all my questions. My appointment was long and I never felt rushed
- August 19, 20255 out of 5 Stars
Dr Marcott provided a summary of prior treatments, asked questions about how prior treatments worked and explained her proposed treatment for that day. She skillfully delivered the treatment and asked about my tolerance throughout.
- August 19, 20255 out of 5 Stars
Dr. Marcott was so pleasant to talk and attentive to my concern. She discussed my concerns with clarity and ease. She was knowledgeable and up to date about my illness. I strongly recommend her if ever there are patients that has the same concern as me.
- August 12, 20255 out of 5 Stars
Very good tension
- August 3, 20255 out of 5 Stars
Very empathetic
- July 17, 20254.9 out of 5 Stars
Have had Parkinson's consultation before. This one more thorough, knowledgeable and personalized than my previous ones. Can't recommend this doctor highly enough.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.